These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7835380)

  • 21. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral sumatriptan compared with placebo in the acute treatment of migraine.
    Nappi G; Sicuteri F; Byrne M; Roncolato M; Zerbini O
    J Neurol; 1994 Jan; 241(3):138-44. PubMed ID: 8164015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term experience with sumatriptan in the treatment of migraine.
    Tansey MJ; Pilgrim AJ; Martin PM
    Eur Neurol; 1993; 33(4):310-5. PubMed ID: 8394239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache.
    Dechant KL; Clissold SP
    Drugs; 1992 May; 43(5):776-98. PubMed ID: 1379152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan.
    Solbach MP; Waymer RS
    Obstet Gynecol; 1993 Nov; 82(5):769-72. PubMed ID: 8414324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sumatriptan in the acute treatment of migraine.
    Tansey MJ; Pilgrim AJ; Lloyd K
    J Neurol Sci; 1993 Jan; 114(1):109-16. PubMed ID: 8381852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open study of self-administration of subcutaneous sumatriptan to treat successive attacks of acute migraine. Portuguese Sumatriptan Auto-injector Study Group.
    J Int Med Res; 1994; 22(4):225-35. PubMed ID: 7958382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sumatriptan: a selective 5-hydroxytryptamine receptor agonist for the acute treatment of migraine.
    Fullerton T; Gengo FM
    Ann Pharmacother; 1992 Jun; 26(6):800-8. PubMed ID: 1319244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral sumatriptan in the acute treatment of migraine and migraine recurrence in general practice.
    Scott RJ; Aitchison WR; Barker PR; McLaren GI
    QJM; 1996 Aug; 89(8):613-22. PubMed ID: 8935482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical profile of sumatriptan: safety and tolerability.
    Lloyd K
    Eur Neurol; 1994; 34 Suppl 2():40-3. PubMed ID: 7835382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
    Winner P; Rothner AD; Wooten JD; Webster C; Ames M
    Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [18 months long-term analysis of effectiveness, safety and tolerance of sumatriptan s.c. in acute therapy of migraine attacks].
    Göbel H; Stolze H; Heinze A; Dworschak M; Heuss D; Christiani K; Lindner V
    Nervenarzt; 1996 Jun; 67(6):471-83. PubMed ID: 8767202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic applications for subcutaneous triptans in the acute treatment of migraine.
    Erlichson K; Waight J
    Curr Med Res Opin; 2012 Jul; 28(7):1231-8. PubMed ID: 22401601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths.
    Cutler N; Mushet GR; Davis R; Clements B; Whitcher L
    Neurology; 1995 Aug; 45(8 Suppl 7):S5-9. PubMed ID: 7644082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of needle-free sumatriptan injection for rapid control of migraine.
    Rothrock JF; Freitag FG; Farr SJ; Smith EF
    Headache; 2013 Sep; 53 Suppl 2():21-33. PubMed ID: 24024600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat.
    Tfelt-Hansen P
    Cephalalgia; 1998 Oct; 18(8):532-8. PubMed ID: 9827244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine.
    Silberstein SD; Mannix LK; Goldstein J; Couch JR; Byrd SC; Ames MH; McDonald SA; Lener SE; Toso C
    Neurology; 2008 Jul; 71(2):114-21. PubMed ID: 18606965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice.
    Russell MB; Holm-Thomsen OE; Rishøj Nielsen M; Cleal A; Pilgrim AJ; Olesen J
    Cephalalgia; 1994 Aug; 14(4):291-6. PubMed ID: 7954759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A sumatriptan iontophoretic transdermal system for the acute treatment of migraine.
    Goldstein J; Smith TR; Pugach N; Griesser J; Sebree T; Pierce M
    Headache; 2012 Oct; 52(9):1402-10. PubMed ID: 22694484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine.
    Pascual J; Bussone G; Hernandez JF; Allen C; Vrijens F; Patel K;
    Eur Neurol; 2001; 45(4):275-83. PubMed ID: 11385269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.